PDS Biotechnology Corp (NAS:PDSB)
$ 3.51 -0.32 (-8.36%) Market Cap: 128.74 Mil Enterprise Value: 107.77 Mil PE Ratio: 0 PB Ratio: 4.85 GF Score: 33/100

PDS Biotechnology Corp Head And Neck Cancer KOL Roundtable Transcript

Oct 26, 2022 / 12:30PM GMT
Release Date Price: $5.14 (-5.17%)
Operator

Greetings, and welcome to the PDS Biotech head and neck cancer KOL roundtable. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Dr. Lauren V. Wood, Chief Medical Officer for PDS Biotech. Dr. Wood, please proceed.

Lauren V. Wood
PDS Biotechnology Corporation - Chief Medical Officer

Good morning, everyone, and welcome to PDS Biotech's head and neck cancer KOL roundtable webcast. With me today are Dr. Neil Gross from the University of Texas, MD Anderson Cancer Center; Dr. Katharine Price from the Mayo Clinic Comprehensive Cancer Center; and Dr. Jared Weiss from the UNC Lineberger Cancer Center.

I will provide formal introductions in a moment, but before we begin, I would like to caution listeners that comments made during this webcast may include forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve material risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot